EUCTR2012-004297-26-IT进行中（未招募）不适用
Phase III clinical study of PET-TC with [18f]Fluoroethyilcholine ([18f]Fech) in prostate cancer: assessment of the additional role with respec to conventional imaging techniques
POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI0 个研究点目标入组 750 人开始时间: 2012年10月16日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 750
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •- adult male patients with a) known untreated prostate cancer (biopsy); b) biochemical recurrence of prostate cancer after prostatectomy (PSA> 1 ng/ml or PSA doubling time < 3 months); - availability to participate to the study (informed consent); - patients suitable for the diagnostic procedure (PET-TC with 18F-FECh);
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 150
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 600
排除标准
- •- patients with recent diagnosis of prostate cancer who started hormone therapy; - patients not suitable for the study protocol;
研究者
相似试验
招募中
不适用
Pilot study using Fluorine-18 Sodium Fluoride PET/CT in diagnosing of skeletal metastases in men with prostate cancer.metastasesspread of cancer10027476NL-OMON36047Isala Klinieken90
进行中（未招募）
不适用
Phase III prospective clinical trial: 18F-FCH/PET evaluation in early diagnosis of disease recurrence in prostate cancer - FCH_PETEUCTR2009-011189-27-ITISTITUTI FISIOTERAPICI OSPITALIERI
进行中（未招募）
1 期
18F-fluoride PET for Early Non-invasive Assessment of Cortical Bone Formation - Non-invasive Assessment of Cortical Bone Formation - Version 1EUCTR2009-016523-61-GBKing’s College London30
进行中（未招募）
不适用
Evaluation of [18F]Fluorocholine PET/CT imaging for staging and restaging of prostate cancer - 18F-FCHPATIENTS AFFECTED BY PROSTATIC CANCERMedDRA version: 9.1Level: PTClassification code 10036222EUCTR2009-016686-28-ITAZIENDA OSPEDALIERA DI PARMA
招募中
2 期
FET PET in Differentiating Tumour Progression From Pseudoprogression in High Grade GliomaGlioma, MalignantNCT06172595Singapore General Hospital22